High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. (Q44642096)
Jump to navigation
Jump to search
scientific article published on 3 November 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. |
scientific article published on 3 November 2003 |
Statements
High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962 (English)
Philip M P Poortmans
Hanny Haaxma-Reiche
Mars Van't Veer
Mads Hansen
Martin Taphoorn
José Thomas
Martin Fickers
Gustaaf Van Imhoff
Cynthia Rozewicz
Ivana Teodorovic
Martine van Glabbeke
European Organization for Research and Treatment of Cancer Lymphoma Group
3 November 2003